Healthcare Business

Biotechnology word cloud

Why Endo Wants to Acquire Auxilium So Much

Endo International PLC (NASDAQ: ENDP) made an unsolicited buyout offer to Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). This news comes right after Auxilium announced that it entered into an agreement to ...
Read Full Story »
95992888

Is Avanir Pharma Fully Valued After Monday’s Rally?

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) posted amazing gains on Monday following the announcement of a successful Phase 1 trial for AVP-923. On the day, Avanir's stock price rose by 85% to ...
Read Full Story »
ReWalker

ReWalk Goes From Marching to Sprinting

Shares of ReWalk Robotics Ltd. (NASDAQ: RWLK) surged again on Monday, following its initial public offering on Friday. The 3 million shares of common stock from the IPO were priced ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
481519631

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) announced positive Phase 2 results for its drug candidate AVP-923. The drug candidate is a potential new therapy for agitation and aggression in patients with ...
Read Full Story »
research

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharmaceuticals Inc. (NASDAQ: NPSP) is trading lower on what sounded like good news. The problem is that headlines often do not reveal the underlying story. After its shares were ...
Read Full Story »
145922793

Deep Discount for Health Care REIT Secondary Offering

Health Care REIT Inc. (NYSE: HCN) has joined the waves of companies looking to raise capital after strong share price gains. The senior living and health care properties real estate ...
Read Full Story »
Biotechnology word cloud

Short Sellers Remain Vigilant Against Biotechs

The short interest report is out for the August 29 settlement date, and 24/7 Wall St. is focusing on the biotech sector. Short sellers are often active in biotech stocks, ...
Read Full Story »
DNA

Virobay Files For Initial Public Offering

Virobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given for the offering but the filing is for up to $50 million ...
Read Full Story »
145922793

Does New Data Make or Break NPS Pharmaceuticals?

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical trial. The FDA has posted the briefing materials prior to ...
Read Full Story »
DNA

IPO Filing: Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given for the offering, but it is valued ...
Read Full Story »
Comfortable hospital bed

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

If any recent subject has generated controversy, it has been the Affordable Care Act (ACA), or Obamacare as it is also known. The reality is that while it may have ...
Read Full Story »
research

IPO Filing: PRA Health Sciences — from KKR

PRA Health Sciences Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given but the total amount for the ...
Read Full Story »
Biotechnology word cloud

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Biotech stock investing can be a nerve-racking experience for investors, especially if they are focused on the companies that are waiting on some sort of binary event or clinical data ...
Read Full Story »
Biotechnology word cloud

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

The firms we cover on Wall Street are sometimes like covering the major sports teams. Analysts are like the top players and tend to move around as their career strengths ...
Read Full Story »